New Daily Persistent Headache Survey

New Daily Persistent Headache Patient Experience Survey

NCT05984719•The University of Texas Health Science Center, Houston

Summary

Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey. Research design: Online survey of patients with new daily persistent headache. Risks: Risks include a breach of confidentiality as well as fatigue from taking the survey online. Importance of knowledge that may recently be expected to result: The study aims to discover new information in a very understudied disease. This information could, in future studies, help change the diagnostic criteria or lead to new treatment options.

Eligibility

Age

13 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with NDPH that have been diagnosed by a health care professional (no documentation is needed, participant must simply state that he or she has been diagnosed)

Exclusion Criteria

•Unable to speak English (the survey is only in English)
•Unable to use a computer to take the online survey

Locations (1)

UTHealth Houston

Houston, Texas, United States

Key Dates

Start Date

June 19, 2023

Primary Completion Date

January 31, 2024

Completion Date

January 31, 2024

Last Updated

February 18, 2026

Enrollment

803

ACTUAL participants

Conditions

New Daily Persistent Headache (NDPH)New Daily Persistent Headache

China HeadAche DIsorders RegiStry

NCT05334927

Headache Disorders, PrimaryMigraine+4 more

View study

WITHDRAWNNA

Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)

NCT05310227

New Daily Persistent Headache (NDPH)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 18, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions